Send to

Choose Destination
J Anaesthesiol Clin Pharmacol. 2018 Oct-Dec;34(4):548. doi: 10.4103/joacp.JOACP_155_18.

Response to: "Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis".

Author information

Global Medical Affairs, Pfizer Inc., New York, NY, USA.
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.
Formerly of Pfizer Global Research and Development (Rinat), Pfizer Inc., South San Francisco, California, USA.

Comment on

Conflict of interest statement

Leslie Tive is a full-time employee of, and own stock and/or stock options in, Pfizer Inc. David Shelton is a consultant for, and owns stock in, Pfizer Inc. Lars Viktrup is a full-time employee of, and owns stock and/or stock options in, Eli Lilly & Company.

Publication type

Publication type

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center